HEGGIE THERESA sold 43.3% of their position (49.93K shares) of BIOCRYST PHARMACEUTICALS INC on the open market
Open‑market sale worth $504.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/24/2026ACC: 0000882796-26-000017
Director
Since Dec 2018
-49.93K
Net shares
Net seller
$504.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
49.93K acquired · 99.87K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+49.93K
Price / share
$6.30
Trade value
$314.58K
% of position
76.4%
3/20/2026
65.35K→115.28K
Common Stock
Direct
Shares
−49.93K
Price / share
$10.11
Trade value
$504.82K
% of position
43.3%
3/20/2026
115.28K→65.35K
Total
Net shares
+0.00
Net value
-$190.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/20/2026 | M · Option Exercise | +49.93K | $6.30 | $314.58K | 76.4% | 65.35K | 115.28K |
| Common Stock Direct | 3/20/2026 | S · Sale | −49.93K | $10.11 | $504.82K | 43.3% | 115.28K | 65.35K |
| Total | +0.00 | -$190.24K | ||||||
Derivative Transactions1
Automatic Stock Option Grant
Direct
Converts to
Common Stock
49.93K shares
Shares
−49.93K
Strike price
6.30
Held after
0.00
Exercisable
—
3/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Automatic Stock Option Grant Direct | Common Stock49.93K shares | 3/20/2026 | M · Option Exercise | −49.93K | 6.30 | — | 0.00 |